Research findings illustrate role of vitamin D in preventing retinal vein occlusion

News
Article

A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO

Vitamins for sale in a retail store. Image credit: ©ltyuan – stock.adobe.com

Maintaining adequate levels of vitamin D may be beneficial for preventing and managing retinal vein occlusion, studies indicate. Image credit: ©ltyuan – stock.adobe.com

Vitamin D supplementation may play a critical role in preventing retinal vein occlusion (RVO),1 according to the investigators from the Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.

The authors noted the growing body of evidence that suggests that maintaining adequate levels of vitamin D may be beneficial for preventing and managing RVO.2 Therefore, they conducted a literature review and meta-analysis to analyse the relationship between the vitamin D levels and the incidence of RVO.

The principal outcome measures centered on the comparative assessment of vitamin D levels between patients with RVO and those controls without RVO.

The investigators reported that the meta-analysis included 6 studies with a total of 589 participants.

“The results indicated a significant association between vitamin D deficiency and increased risk of RVO (odds ratio = 14.51; 95% confidence interval [CI]: [1.71, 122.59], p = 0.014); and patients with RVO exhibited a significant decrease in serum vitamin D levels by 1.91 ng/mL (95% CI: [-2.29, -1.54], p < 0.001),” the authors reported.

Another finding was that no significant difference in the levels of vitamin D was seen between central RVO and branch RVO subtypes (P = 0.63).

The investigators reached the conclusion that patients with RVO have more vitamin D deficiency compared with healthy controls.

“These results contribute to the growing body of evidence highlighting the intricate role of vitamin D supplementation as both a prophylactic and a treatment strategy in RVO,” the authors said.

They also offered the caveat that in order to comprehensively understand the potential roles and mechanisms, further investigations, especially clinical trials, must be undertaken that specifically explore the impact of vitamin D supplementation on the central macular thickness and the prognosis of the best-corrected visual acuity in patients with RVO. New information will help to improve treatment strategies.

References

  1. Daneshvar K, Akhlaghi M, Iranpour S, Irajpour M, Pourazizi M. Vitamin D deficiency in patients with retinal vein occlusion: a systematic review and meta-analysis Int J Retin Vitr. 2024;10:52; https://doi.org/10.1186/s40942-024-00571-3
  2. Karimi S, Parvizi F, Arabi A, Shahraki T, Safi S. Oral vitamin D supplementation and clinical outcomes of intravitreal bevacizumab injection for macular edema secondary to retinal vein occlusions. J Ophthalmic Vis Res. 2022;17:376–383.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.